{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:37:21Z","timestamp":1790771841072,"version":"4.1.0"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1097\/ajp.0b013e318196d2b6","type":"journal-article","created":{"date-parts":[[2009,5,21]],"date-time":"2009-05-21T10:35:02Z","timestamp":1242902102000},"page":"376-385","source":"Crossref","is-referenced-by-count":121,"title":["Efficacy and Safety of Lacosamide in Diabetic Neuropathic Pain"],"prefix":"10.1097","volume":"25","author":[{"given":"James P.","family":"Wymer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Sen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Bongardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210204","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.2337\/diacare.27.7.1591","article-title":"Prevalence of lower-extremity disease in the US adult population \u226540 years of age with and without diabetes: 1999-2000 national health and nutrition examination survey","volume":"27","author":"Gregg","year":"2004","journal-title":"Diabetes Care"},{"key":"R2-4-20210204","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3132\/dvdr.2006.013","article-title":"New perspectives on the management of diabetic peripheral neuropathic pain","volume":"3","author":"Jensen","year":"2006","journal-title":"Diab Vasc Dis Res"},{"key":"R3-4-20210204","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/00002508-200211000-00002","article-title":"Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy","volume":"18","author":"Schmader","year":"2002","journal-title":"Clin J Pain"},{"key":"R4-4-20210204","doi-asserted-by":"crossref","first-page":"956","DOI":"10.2337\/diacare.28.4.956","article-title":"Diabetic neuropathies: a statement by the American Diabetes Association","volume":"28","author":"Boulton","year":"2005","journal-title":"Diabetes Care"},{"key":"R5-4-20210204","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1177\/106002809502907-820","article-title":"Peripheral diabetic neuropathy: current concepts in treatment","volume":"29","author":"Calissi","year":"1995","journal-title":"Ann Pharmacother"},{"key":"R6-4-20210204","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0304-3959(96)03140-5","article-title":"A systematic review of antidepressants in neuropathic pain","volume":"68","author":"McQuay","year":"1996","journal-title":"Pain"},{"key":"R7-4-20210204","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1212\/01.WNL.0000057720.36503.2C","article-title":"Controlled-release oxycodone for pain in diabetic neuropathy: a randomized controlled trial","volume":"60","author":"Gimbel","year":"2003","journal-title":"Neurology"},{"issue":"1","key":"R8-4-20210204","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1002\/dmrr.361","article-title":"Treatment of symptomatic diabetic neuropathy","volume":"19","author":"Boulton","year":"2003","journal-title":"Diabetes Metab Res Rev"},{"key":"R9-4-20210204","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.pain.2005.03.029","article-title":"Duloxetine versus placebo in patients with painful diabetic neuropathy","volume":"116","author":"Goldstein","year":"2005","journal-title":"Pain"},{"key":"R10-4-20210204","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1001\/jama.280.21.1831","article-title":"Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial","volume":"280","author":"Backonja","year":"1998","journal-title":"JAMA"},{"key":"R11-4-20210204","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1212\/WNL.52.2.321","article-title":"Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults","volume":"52","author":"Martin","year":"1999","journal-title":"Neurology"},{"key":"R12-4-20210204","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1212\/WNL.57.3.505","article-title":"Lamotrigine reduces painful diabetic neuropathy: a randomized, controlled study","volume":"57","author":"Eisenberg","year":"2001","journal-title":"Neurology"},{"key":"R13-4-20210204","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0149-2918(03)90011-7","article-title":"Gabapentin dosing for neuropathic pain: evidence from randomized, placebo-controlled clinical trials","volume":"25","author":"Backonja","year":"2003","journal-title":"Clin Ther"},{"key":"R14-4-20210204","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00002508-200301000-00008","article-title":"The rationale and use of topiramate for treating neuropathic pain","volume":"19","author":"Chong","year":"2003","journal-title":"Clin J Pain"},{"key":"R15-4-20210204","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1212\/01.WNL.0000145767.36287.A1","article-title":"Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial","volume":"63","author":"Lesser","year":"2004","journal-title":"Neurology"},{"key":"R16-4-20210204","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1212\/01.WNL.0000152877.08088.87","article-title":"Effects of topiramate and gabapentin on cognitive abilities in healthy volunteers","volume":"64","author":"Salinsky","year":"2005","journal-title":"Neurology"},{"key":"R17-4-20210204","doi-asserted-by":"crossref","first-page":"4936","DOI":"10.1210\/jc.2004-2376","article-title":"Clinical review: Use of antiepileptic drugs in the treatment of chronic painful diabetic neuropathy","volume":"90","author":"Vinik","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"R18-4-20210204","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/WCO.0b013e328285dfd6","article-title":"Treatment of painful neuropathy","volume":"20","author":"Cruccu","year":"2007","journal-title":"Curr Opin Neurol"},{"key":"R19-4-20210204","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.neulet.2003.08.036","article-title":"Does SPM 927 have an analgesic effect in human neuropathic pain? An open label study","volume":"352","author":"McCleane","year":"2003","journal-title":"Neurosci Lett"},{"key":"R20-4-20210204","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1527-3458.2007.00001.x","article-title":"Lacosamide: a review of preclinical properties","volume":"13","author":"Beyreuther","year":"2007","journal-title":"CNS Drug Rev"},{"key":"R21-4-20210204","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.nurt.2006.10.002","article-title":"Lacosamide","volume":"4","author":"Doty","year":"2007","journal-title":"Neurotherapeutics"},{"key":"R22-4-20210204","first-page":"508","article-title":"Antinociceptive properties of the anti-convulsant SPM 927 (harkoseride) in rat","volume":"27","author":"Morrow","year":"2001","journal-title":"Soc Neurosci Abstr"},{"key":"R23-4-20210204","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ejphar.2006.04.009","article-title":"Antinociceptive efficacy of lacosamide in a rat model for painful diabetic neuropathy","volume":"539","author":"Beyreuther","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"R24-4-20210204","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ejphar.2006.09.040","article-title":"Lacosamide, a new anti-epileptic, alleviates neuropathic pain-like behaviors in rat models of spinal cord or trigeminal nerve injury","volume":"553","author":"Hao","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"R25-4-20210204","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ejpain.2005.04.002","article-title":"Lacosamide displays potent antinociceptive effects in animal models for inflammatory pain","volume":"10","author":"Stohr","year":"2006","journal-title":"Eur J Pain"},{"key":"R26-4-20210204","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1124\/mol.107.039867","article-title":"The investigational anticonvulsant lacosamide selectively enhances slow inactivation of voltage-gated sodium channels 10.1124\/mol.107.039867","volume":"73","author":"Errington","year":"2008","journal-title":"Mol Pharmacol"},{"key":"R27-4-20210204","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1124\/jpet.107.133413","article-title":"Differential block of sensory neuronal voltage-gated sodium channels by lacosamide, lidocaine and carbamazepine","volume":"326","author":"Sheets","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"R28-4-20210204","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1111\/j.1471-4159.2006.03969.x","article-title":"Calpain product of WT-CRMP2 reduces the amount of surface NR2B NMDA receptor subunit","volume":"98","author":"Bretin","year":"2006","journal-title":"J Neurochem"},{"key":"R29-4-20210204","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0920-1211(02)00106-7","article-title":"Progress report on new antiepileptic drugs: a summary of the Sixth Eilat Conference (EILAT VI)","volume":"51","author":"Bialer","year":"2002","journal-title":"Epilepsy Res"},{"key":"R30-4-20210204","first-page":"479","article-title":"SPM-927 (Schwarz Pharma)","volume":"6","author":"Hovinga","year":"2003","journal-title":"IDrugs"},{"issue":"7","key":"R31-4-20210204","first-page":"313","article-title":"Pharmacokinetics of the new antiepileptic drug SPM 927 in human subjects with different age and gender","volume":"45","author":"Schiltmeyer","year":"2004","journal-title":"Epilepsia"},{"key":"R32-4-20210204","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2006.10.008","article-title":"Progress report on new antiepileptic drugs: a summary of the Eighth Eilat conference (EILAT VIII)","volume":"73","author":"Bialer","year":"2007","journal-title":"Epilepsy Res"},{"key":"R34-4-20210204","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/01.ajp.0000210957.39621.b2","article-title":"Lacosamide in painful diabetic peripheral neuropathy: a phase 2 double-blind placebo-controlled study","volume":"23","author":"Rauck","year":"2007","journal-title":"Clin J Pain"},{"key":"R35-4-20210204","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0304-3959(01)00349-9","article-title":"Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale","volume":"94","author":"Farrar","year":"2001","journal-title":"Pain"},{"key":"R36-4-20210204","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S0885-3924(03)00162-3","article-title":"Clinically important changes in acute pain outcome measures: a validation study","volume":"25","author":"Farrar","year":"2003","journal-title":"J Pain Symptom Manage"},{"key":"R37-4-20210204","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.jpain.2006.01.168","article-title":"A multi-center, open-label, follow-on trial to assess the long-term safety and efficacy of lacosamide in subjects with painful distal diabetic neuropathy","volume":"7","author":"Bretschneider","year":"2006","journal-title":"J Pain"},{"key":"R38-4-20210204","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1212\/01.WNL.0000137341.89781.14","article-title":"Topiramate vs placebo in painful diabetic neuropathy: analgesic and metabolic effects","volume":"63","author":"Raskin","year":"2004","journal-title":"Neurology"},{"key":"R39-4-20210204","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.pain.2005.02.032","article-title":"Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens","volume":"115","author":"Freynhagen","year":"2005","journal-title":"Pain"},{"key":"R40-4-20210204","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.pain.2004.05.010","article-title":"Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study","volume":"110","author":"Rowbotham","year":"2004","journal-title":"Pain"},{"key":"R41-4-20210204","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.pain.2004.05.001","article-title":"Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial","volume":"110","author":"Rosenstock","year":"2004","journal-title":"Pain"},{"key":"R42-4-20210204","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jpain.2004.12.007","article-title":"Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial","volume":"6","author":"Richter","year":"2005","journal-title":"J Pain"},{"key":"R43-4-20210204","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1600-0404.2004.00338.x","article-title":"Topiramate in painful diabetic polyneuropathy: findings from three double-blind placebo-controlled trials","volume":"110","author":"Thienel","year":"2004","journal-title":"Acta Neurol Scand"},{"key":"R44-4-20210204","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1526-4637.2005.00061.x","article-title":"A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain","volume":"6","author":"Raskin","year":"2005","journal-title":"Pain Med"},{"key":"R45-4-20210204","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ejpain.2004.11.006","article-title":"Oxcarbazepine in painful diabetic neuropathy: a randomized, placebo-controlled study","volume":"9","author":"Dogra","year":"2005","journal-title":"Eur J Pain"},{"key":"R46-4-20210204","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1600-0404.2006.00631.x","article-title":"Oxcarbazepine in painful diabetic neuropathy: results of a dose-ranging study","volume":"113","author":"Beydoun","year":"2006","journal-title":"Acta Neurol Scand"}],"container-title":["The Clinical Journal of Pain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00002508-200906000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T01:22:17Z","timestamp":1633483337000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002508-200906000-00004"}},"subtitle":["An 18-week Double-blind Placebo-controlled Trial of Fixed-dose Regimens"],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/ajp.0b013e318196d2b6","relation":{},"ISSN":["0749-8047"],"issn-type":[{"value":"0749-8047","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}